Metformin therapy reduces the risk of malignancy after heart transplantation.
Peled Y, Lavee J, Raichlin E, Katz M, Arad M, Kassif Y, Peled A, Asher E, Elian D, Har-Zahav Y, Shlomo N, Freimark D, Goldenberg I, Klempfner R.
Peled Y, et al. Among authors: asher e.
J Heart Lung Transplant. 2017 Dec;36(12):1350-1357. doi: 10.1016/j.healun.2017.06.009. Epub 2017 Jun 23.
J Heart Lung Transplant. 2017.
PMID: 28736111